Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 99(3): 109-132, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37949110

RESUMEN

With the advance of cancer therapy in recent years, the knowledge of the mechanisms involved in this disease has increased, which has meant an increase in the quality of life and survival of patients with tumor pathologies previously considered incurable or refractory to treatment. The number of drugs used has increased exponentially in number, and although the implicit toxicity is lower than that of conventional antineoplastic therapy, they lead to the appearance of new associated adverse effects that the ophthalmologist must recognize and manage.


Asunto(s)
Oftalmólogos , Calidad de Vida , Humanos , Ojo , Cara
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA